絞り込み

16314

広告

アジア各地に邦楽の公演可能なライブホール開設を発表

大手音楽会社のソニー・ミュージックエンタテインメントとそのグループ会社は、官民ファンドの支援を受けて、アジア各地に日本のアーティストなどが公演を行えるライブホー...

  1. ヒートショックプロテインを増やす入浴法 ...
  2. 痛風対策してますか?食事・運動・サプリメ...
  3. 英エコノミスト誌が予測「日本は人口減少で...
  4. 高浜原発4号機 燃料入れる作業始まる 来...

ニュース一覧

「ranibizumab」の検索結果

3403件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.

Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.

Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.

Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept.

Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study.

Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.

Ahmed valves vs trabeculectomy combined with pans plana vitrectomy for neovascular glaucoma with vitreous hemorrhage.

Anti-Vascular Endothelial Growth Factor Injections: The New Standard of Care in Proliferative Diabetic Retinopathy?

Practical Lessons from Protocol T for the Management of Diabetic Macular Edema.

Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.

Intravitreal Aflibercept in Diabetic Macular Edema: Long-Term Outcomes.

Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes.

Long-Term Anatomical and Functional Outcomes in Patients with Ischemic Central Retinal Vein Occlusion Treated with Anti-Vascular Endothelial Growth Factor Agents.

INTRAVITREAL DEXAMETHASONE IMPLANTATION IN PATIENTS WITH DIFFERENT MORPHOLOGICAL DIABETIC MACULAR EDEMA HAVING INSUFFICIENT RESPONSE TO RANIBIZUMAB.

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.

Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります